Angiogenesis promoter and therapeutic method
US12171810B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Oct 2, 2019 |
| Grant date | Dec 24, 2024 |
| Priority date | — |
| Expiry date | Nov 1, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention addresses the problem of providing an angiogenesis promoter capable of exerting an excellent angiogenesis promoting effect without containing any growth factor. The present invention also addresses the problem of providing a therapeutic method. An angiogenesis promoter that comprises as an active ingredient at least one member selected from the group consisting of a gelatin derivative represented by formula 1 and a crosslinked product of the gelatin derivative:In formula 1: Gltn represents a gelatin residue; L represents a single bond or a divalent linking group; and R1 and R2 independently represent a hydrocarbon group having 1-20 carbon atoms or a hydrogen atom, provided that at least one of R1 and R2 represents the aforesaid hydrocarbon group.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.